Brivanib (BMS-582664) in advanced soft-tissue sarcoma (STS): Biomarker and subset results of a phase II randomized discontinuation trial Meeting Abstract
| Authors: | Schwartz, G. K.; Maki, R. G.; Ratain, M. J.; Undevia, S. D.; Jones, R. L.; Rudin, C. M.; Siu, L. L.; Brockstein, B.; Khayat, D.; Gil, T.; De Jonge, M. J.; Sawyer, M. B.; Evans, T. R. J.; Medioni, J.; O'Dwyer, P. J.; Hartman, C.; Poulart, V.; Walters, I. B. |
| Abstract Title: | Brivanib (BMS-582664) in advanced soft-tissue sarcoma (STS): Biomarker and subset results of a phase II randomized discontinuation trial |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880301018 |
| DOI: | 10.1200/jco.2011.29.15_suppl.10000 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 10000 -- Source: Wos |
Altmetric
Citation Impact
